0 01/04/2023 31/03/2024 2024-03-31 false false false false false false false true false false true false false false false false true false No description of principal activities is disclosed 2023-04-01 Sage Accounts Production 23.0 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 08405477 2023-04-01 2024-03-31 08405477 2024-03-31 08405477 2023-03-31 08405477 2022-04-01 2023-03-31 08405477 2023-03-31 08405477 2022-03-31 08405477 bus:RegisteredOffice 2023-04-01 2024-03-31 08405477 bus:LeadAgentIfApplicable 2023-04-01 2024-03-31 08405477 bus:Director1 2023-04-01 2024-03-31 08405477 bus:Director2 2023-04-01 2024-03-31 08405477 bus:Director3 2023-04-01 2024-03-31 08405477 bus:CompanySecretary1 2023-04-01 2024-03-31 08405477 core:RetainedEarningsAccumulatedLosses 2022-04-01 2023-03-31 08405477 core:RetainedEarningsAccumulatedLosses 2023-04-01 2024-03-31 08405477 core:WithinOneYear 2024-03-31 08405477 core:WithinOneYear 2023-03-31 08405477 core:ShareCapital 2024-03-31 08405477 core:ShareCapital 2023-03-31 08405477 core:RetainedEarningsAccumulatedLosses 2024-03-31 08405477 core:RetainedEarningsAccumulatedLosses 2023-03-31 08405477 core:ShareCapital 2022-03-31 08405477 core:RetainedEarningsAccumulatedLosses 2022-03-31 08405477 core:PreviouslyStatedAmount core:ShareCapital 2024-03-31 08405477 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 08405477 core:Non-currentFinancialInstruments 2024-03-31 08405477 core:Non-currentFinancialInstruments 2023-03-31 08405477 bus:SmallEntities 2023-04-01 2024-03-31 08405477 bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 08405477 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 08405477 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 08405477 bus:AbridgedAccounts 2023-04-01 2024-03-31
Company registration number: 08405477
Cnepin Investments Limited
Trading as Cnepin Investments
Unaudited filleted abridged financial statements
31 March 2024
Cnepin Investments Limited
Contents
Directors and other information
Abridged statement of financial position
Statement of changes in equity
Notes to the financial statements
Cnepin Investments Limited
Directors and other information
Directors Mr David Jones
Mr Michael Newbold
Mr Gareth Perkins
Secretary David E Jones
Company number 08405477
Registered office The Grange
Castle Lane
Penhow
NP26 3AD
Bankers Barclays plc
1 Churchill Place
London
E14 5HP
Solicitors Morgan La Roche
Bay House
Swansea
SA7 9YT
Cnepin Investments Limited
Abridged statement of financial position
31 March 2024
Note £ £ £ £
Fixed assets
Investments 4 33,080 33,580
_______ _______
33,080 33,580
Current assets
Debtors 150 150
Cash at bank and in hand 212 168
_______ _______
362 318
Creditors: amounts falling due
within one year ( 18,747) ( 18,747)
_______ _______
Net current liabilities ( 18,385) ( 18,429)
_______ _______
Total assets less current liabilities 14,695 15,151
_______ _______
Net assets 14,695 15,151
_______ _______
Capital and reserves
Called up share capital 150 150
Profit and loss account 14,545 15,001
_______ _______
Shareholders funds 14,695 15,151
_______ _______
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the abridged statement of comprehensive income has not been delivered.
All of the members have consented to the preparation of the abridged statement of comprehensive income and the abridged statement of financial position for the current year ending 31 March 2024 in accordance with Section 444(2A) of the Companies Act 2006.
These financial statements were approved by the board of directors and authorised for issue on 23 September 2023 , and are signed on behalf of the board by:
Mr David Jones
Director
Company registration number: 08405477
Cnepin Investments Limited
Statement of changes in equity
Year ended 31 March 2024
Called up share capital Profit and loss account Total
£ £ £
At 1 April 2022 150 15,457 15,607
Loss for the year ( 456) ( 456)
_______ _______ _______
Total comprehensive income for the year - ( 456) ( 456)
_______ _______ _______
At 31 March 2023 and 1 April 2023 150 15,001 15,151
Loss for the year ( 456) ( 456)
_______ _______ _______
Total comprehensive income for the year - ( 456) ( 456)
_______ _______ _______
At 31 March 2024 150 14,545 14,695
_______ _______ _______
Cnepin Investments Limited
Notes to the financial statements
Year ended 31 March 2024
1. General information
The company is a private company limited by shares, registered in Wales. The address of the registered office is The Grange, Castle Lane, Penhow, NP26 3AD.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Fixed asset investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses. Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Investments
£
Cost
At 1 April 2023 and 31 March 2024 33,080
_______
Impairment
At 1 April 2023 and 31 March 2024 -
_______
Carrying amount
At 31 March 2024 33,080
_______
At 31 March 2023 33,080
_______